Researchers used the CRISPR-ON method to upregulate KLF4 expression in a study, which looked at the effect and mechanism of KLF4 in the carcinogenesis and development of urothelial bladder cancer (UBC). Here, KLF4 is linked to bladder transitional cell carcinoma.